Subscribe: Market Wire - Medical and Healthcare: Surgery and Treatments
Added By: Feedage Forager Feedage Grade A rated
Language: English
announces  cannabis  clinical  company  marketwired sep  marketwired september  marketwired  medical  new  pain  september  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Surgery and Treatments

Marketwired - Surgery and Treatments

Marketwired - Surgery and Treatments

Last Build Date: Wed, 28 Sep 2016 16:44:39 EDT

Copyright: Copyright: (C) Marketwired

InspireMD Announces 1-for-25 Reverse Stock Split

Wed, 28 Sep 2016 16:01:00 EDT

BOSTON, MA--(Marketwired - Sep 28, 2016) - InspireMD, Inc. (NYSE MKT: NSPR) (NYSE MKT: NSPR.WS) ("InspireMD" or the "Company"), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced a 1-for-25 reverse split of its common stock, effective as of October 7, 2016. Beginning on October 10, 2016, the Company's common stock will trade on the NYSE MKT on a split adjusted basis.

Medtronic, Phillips Healthcare Lead High Demand Billion Dollar U.S. Patient Monitoring Market

Wed, 28 Sep 2016 13:17:54 EDT

The U.S. Patient Monitoring Market Is Expected to Grow Over the Next Several Years to Reach Over $6 Billion by 2023

NCCN Congress to Explore Complex Issues in Treating Hematologic Malignancies

Wed, 28 Sep 2016 13:15:00 EDT

The NCCN 11th Annual Congress: Hematologic Malignancies(TM) Returns to New York City September 30 - October 1, 2016; Registration Is Still Open at

Commence Bio to Present at 2016 Cell & Gene Meeting on the Mesa

Wed, 28 Sep 2016 12:37:22 EDT

SPARKS, MD--(Marketwired - September 28, 2016) - Commence Bio, Inc., a biotechnology company focused on developing breakthrough immunotherapies using its proprietary STaRTT platform, announced today that Thomas Isett, CEO and Co-Founder, will present a company overview at the 2016 Cell & Gene Meeting on the Mesa [CGMOM]. Scheduled for October 5, at 2:45 PM (PDT), the presentation will highlight developments with the application of STaRT to create MSC1 and MSC2 cellular therapies for immuno-oncology and immune-mediated inflammatory diseases.

Cannabis Science Launches New Medicinal Product Line in Legal Dispensaries Within the State of California for Self-Medicating Patients

Wed, 28 Sep 2016 10:40:45 EDT

IRVINE, CA--(Marketwired - Sep 28, 2016) -  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce Cannabis Science launches new medicinal product lines for self-medicating patients via legal dispensaries and delivery within the State of California. The new CBIS medicinal product lines are being released based on patient usage data and general public opinion. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize target medicines for target ailments. These new medicinal products will be centerpieces for its new medicinal studies targeting its initial critical ailment list.

Predicine Celebrates Grand Opening of Its R&D Facilities in Shanghai, China

Wed, 28 Sep 2016 09:37:02 EDT

HAYWARD, CA--(Marketwired - Sep 28, 2016) - Predicine celebrated the grand opening of its new R&D facilities in Shanghai, China, with a launch ceremony honoring the occasion on September 26, 2016. Invited dignitaries included government officials, collaborators and customers from leading hospitals, universities and pharmaceutical companies.

The Alliance for Regenerative Medicine Announces Fourth Annual 2016 European Advanced Therapies Investor Day

Wed, 28 Sep 2016 09:00:00 EDT

WASHINGTON, DC--(Marketwired - Sep 28, 2016) - The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, announced its annual European Advanced Therapies Investor Day will be held November 3, 2016 in London.

Defining Patient-Centricity Success Metrics & Demonstrating Initiative Value

Wed, 28 Sep 2016 08:31:00 EDT

20% of Pharmaceutical Companies Struggle Due to Increased Focus on Consumer Experience

Palm Beach Plastic Surgeons Discuss Cellulite Treatment With Cellfina

Wed, 28 Sep 2016 07:01:00 EDT

Dr. Mark Pinsky and Dr. David Lickstein Recently Began Offering Cellfina Treatments to Minimize the Appearance of Cellulite for Smoother Thighs and Buttocks

Washington, DC Ophthalmologists Now Offering TECNIS Symfony IOL for Presbyopia

Wed, 28 Sep 2016 07:01:00 EDT

Eye Doctors of Washington Announces the Addition of the TECNIS Symfony Intraocular Lens (IOL) to Its Procedural Offerings

Synensys Opens Qatar Office to Provide Innovative Health System Strengthening Solutions

Wed, 28 Sep 2016 04:00:00 EDT

As the First International Healthcare Consulting Firm to Locate in Qatar Financial Centre (QFC), Synensys Plans to Be Part of the Healthcare Transformation That Is Currently Taking Hold in the Middle East and North Africa (MENA) Region

Titan Medical Provides Corporate Update

Tue, 27 Sep 2016 16:05:00 EDT

TORONTO, ON--(Marketwired - September 27, 2016) - Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (MIS), today provided an update of corporate activities and operational progress.

Whistler Medical Marijuana Corporation (WMMC), a Certified Organic Licensed Producer of Medical Cannabis, Today Announced the Release of Canada's First High Cannabigerol (CBG) Cannabis Oil

Tue, 27 Sep 2016 13:49:56 EDT

WHISTLER, BC--(Marketwired - September 27, 2016) - The release follows two years of research identifying the best medical phenotypes from the diverse seed bank at WMMC. The process identified a unique phenotype containing significant amounts of both THC and CBG at maturity which now forms the starting material for their High CBG oil.

Konica Minolta to Exhibit Diagnostic Imaging Portfolio at 2016 Urgent Care Fall Conference

Tue, 27 Sep 2016 11:30:00 EDT

Live Ultrasound Scanning Demonstrations to Be Conducted in Booth

Education Resources Inc. Offers New Acute and Critical Care Therapy Series Online

Tue, 27 Sep 2016 11:18:34 EDT

BOSTON, MA--(Marketwired - September 27, 2016) - To help healthcare professionals address patient stability, prevent hospital readmission, improve early mobilization and progression, improve patient satisfaction, and achieve functional outcomes, Education Resources Inc. is now offering an acute and critical care therapy series online.

Las Vegas Plastic Surgeon Discusses Benefits of Breast Lift With Augmentation

Tue, 27 Sep 2016 10:01:00 EDT

Dr. W. Tracy Hankins of Hankins & Sohn Plastic Surgery Associates Explains How Breast Implants Can Enhance the Results of Breast Lift Surgery

Premier Biomedical Pain Management Solutions Announces Shipment of Initial Samples of Opioid-Free, 50-State Legal, CBD-Based Pain-Relieving Topical Patch

Tue, 27 Sep 2016 10:00:00 EDT

EL PASO, TX--(Marketwired - Sep 27, 2016) -  Premier Biomedical, Inc. (OTCQB: BIEI) announced today their newly created joint venture company, Premier Biomedical Pain Management Solutions, LLC (PBPMS) has manufactured and shipped initial design sample pain relieving topical patches for distribution to select VA hospital patients, military personnel, doctors, and professional sports figures. These patent-pending, opioid- and narcotic-free all-natural-ingredient topical pain relief patches consist of a proprietary mechanism for extended delivery of their cannabis-based medical CBD pain relieving compound, which is legal in all 50 states.

Syus Selects Applause to Ensure Solution Quality Meets the Highest Standards Required by Surgical Teams at Leading Health Systems

Tue, 27 Sep 2016 09:27:00 EDT

Syus Relies on Applause Testers to Validate Data and Provide Quality Assurance for Digital Solutions That Improve Hospital Efficiencies and Increase Access to Patient Care

ChronicCareIQ to Present at Venture Atlanta 2016

Tue, 27 Sep 2016 09:22:54 EDT

Conference Will Showcase the South's Most Promising Technology Companies

RIVANNA Announces Partnership With UK-Based Vertec Scientific

Tue, 27 Sep 2016 09:15:00 EDT

CHARLOTTESVILLE, VA--(Marketwired - September 27, 2016) - RIVANNA, an innovative medical-device company that has developed a revolutionary pocket-sized ultrasound-based device for automated spinal and epidural anesthesia guidance, announces a distribution partnership with UK-based Vertec Scientific.

Inaugural Techonomy Health Roundtable to Explore Healthcare in a Hyper-Connected Age

Tue, 27 Sep 2016 09:00:00 EDT

On November 9, Global Leaders Will Gather to Examine New Technologies, Attitudes and Opportunities Within the Connected Healthcare Ecosystem

The Alliance for Regenerative Medicine Submits Comments in Response to the European Commission's Draft Guidelines on Good Manufacturing Practice for Advanced Therapy Medicine Products

Tue, 27 Sep 2016 09:00:00 EDT

BRUSSELS, BELGIUM and WASHINGTON, DC--(Marketwired - Sep 27, 2016) - The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, has submitted written comments in response to the European Commission (EC)-issued targeted stakeholder consultation document on the draft Guidelines on Good Manufacturing Practice for Advanced Therapy Medicine Products (ATMP).

BioNap Consulting's Jason Napodano Issues an Update on BriaCell Therapeutics Corp.

Tue, 27 Sep 2016 08:30:00 EDT

BERKELEY, CA and VANCOUVER, BC--(Marketwired - September 27, 2016) - BioNap Consulting, Inc.'s Senior Equity Analyst, Jason Napodano, CFA, issued an update outlining the meaningful progress of BriaCell Therapeutics Corp. (TSX VENTURE: BCT) (OTCQB: BCTXF) or BriaCell towards initiation of Phase I/IIa clinical testing of BriaVaxT, BriaCell's proprietary allogeneic whole tumor cell vaccine, in late-stage breast cancer patients in the fourth quarter of 2016.

Breathtec Biomedical Engages DTG Partners to Advance Product Commercialization

Tue, 27 Sep 2016 08:30:00 EDT

Medical Product Development Consultancy Aims to Deliver Proven, Time-Efficient and Cost-Effective Expertise

North Springs Resources Corp. Announces the Unveiling of Major Business Announcement to Shareholders Before Oct 1st 2016

Tue, 27 Sep 2016 08:30:00 EDT

RIVERVIEW, FL--(Marketwired - Sep 27, 2016) - North Springs Resources Corp. (OTC PINK: NSRS) is pleased to announce that the Company has worked closely with the Company's strategic partner and plans to issue an update to shareholders on or before Oct 1st 2016 regarding a contractual agreement that is expected to have a substantial and beneficial impact on the Company and its shareholders.

Top 5 Factors Pharma Companies Consider When Compensating Clinical Investigators

Tue, 27 Sep 2016 08:19:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - September 27, 2016) - The most important factor to determining clinical investigator compensation is the physician's therapeutic specialty, according to a report published by pharmaceutical competitive intelligence firm Cutting Edge Information.

Viveve Submits Investigational Device Exemption (IDE) for VIVEVE II

Tue, 27 Sep 2016 08:02:00 EDT

SUNNYVALE, CA--(Marketwired - September 27, 2016) - Viveve Medical, Inc. ("Viveve") (NASDAQ: VIVE), a medical technology company focused on women's health, today announced submission of an Investigational Device Exemption (IDE) to the Food and Drug Administration (FDA), under a de novo 510K, for authorization to begin the VIveve Treatment of the Vaginal Introitus to EVauate Efficacy (VIVEVE II) study involving use of the Viveve System for the treatment of vaginal tissue to improve sexual function in women. The clinical trial will use the Female Sexual Function Index (FSFI) as the primary efficacy endpoint.

The LAM Foundation Hosts Largest Rare Lung Disease Conference of Its Kind in Cincinnati

Mon, 26 Sep 2016 20:29:52 EDT

New $3.6 Million NIH Grant for MILED Trial and New Clinical Guidelines for LAM Introduced at the Joint Meeting of Scientists and Patients

NuVasive Announces Conference Call and Webcast of Third Quarter 2016 Results

Mon, 26 Sep 2016 16:10:00 EDT

SAN DIEGO, CA--(Marketwired - September 26, 2016) - NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery, today announced that the Company will release its third quarter 2016 earnings results before the markets open on Wednesday, October 26, 2016.

FluoroPharma Announces CardioPET Phase II Results at the 21st American Society of Nuclear Cardiology (ASNC) Meeting

Mon, 26 Sep 2016 12:15:53 EDT

MONTCLAIR, NJ--(Marketwired - September 26, 2016) - FluoroPharma Medical Inc. (OTCQB: FPMI) announced today that data from its Phase II clinical trial for CardioPET were presented at the 21st Annual Meeting of the American Society of Nuclear Cardiology on September 24th, 2016 in Boca Raton, Florida.

NCCN Publishes New Clinical Practice Guidelines for Myeloproliferative Neoplasms

Mon, 26 Sep 2016 12:03:22 EDT

New NCCN Guidelines for Myeloproliferative Neoplasms Focus on the Treatment of Myelofibrosis, a Rare Bone Marrow Cancer; the New Recommendations Are the Most Comprehensive Treatment Guidance Available to U.S. Clinicians Today

Easton Pharmaceuticals Announces Receiving Mexican Regulatory Approval for VagiSan (VS-Sense) Diagnostic Device, in Support of On-Going Exclusive Distribution Negotiations With Multi-National Pharmaceutical Companies for Major Latin American Markets

Mon, 26 Sep 2016 10:45:42 EDT

TORONTO, ON--(Marketwired - Sep 26, 2016) - Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces COFEPRIS (Mexican Ministry of Health) has granted Marketing Authorization for VagiSan (also known as VS-Sense) diagnostic test, supporting on-going exclusive partnership negotiations for Mexico and other Latin American markets with several multinational pharmaceutical companies.

Mr. Raymond C. Dabney, CBIS CEO, Accepts Invitation to Speak at Harvard Medical School

Mon, 26 Sep 2016 10:18:41 EDT

WASHINGTON, DC--(Marketwired - Sep 26, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, announces that its President, Chief Executive Officer, and Co-Founder, Mr. Raymond C. Dabney, has accepted an invitation to speak at Harvard Medical School this November. Mr. Dabney will speak at the Dana Farber/Harvard Cancer Center (DF/HCC), one of the largest cancer research centers in the world with more than 1,100 cancer researchers and over $600 million in cancer research funding. He will discuss CBIS' drug development initiatives targeting a variety of cancers, within the context of a number of other disorders, such as autism spectrum disorders, asthma, as well as pain management.

Vancouver Aesthetic Doctor Compiles Must-Have List of Antioxidant Skincare

Fri, 23 Sep 2016 16:13:21 EDT

Vancouver aesthetic doctor reveals favourite antioxidant products picks for fall

Pain Awareness Month Draws Attention to Chronic Pain as Contributor to Disability, Allsup Reports

Fri, 23 Sep 2016 09:00:00 EDT

Allsup outlines importance of Social Security Disability Insurance for people with chronic pain, offers free SSDI assessment with empower by Allsup(R) and web event on chronic pain

Greengro Technologies, Unveils Advantageous 'GreenGro 3-Tier Franchise Model'

Fri, 23 Sep 2016 07:30:00 EDT

ANAHEIM, CA--(Marketwired - Sep 23, 2016) - Greengro Technologies, Inc. (OTC PINK: GRNH), a world-class provider of eco-friendly green technologies, has announced the "Greengro 3-Tier Franchise Model" for businesses in the field of controlled environment agriculture (CEA). The three tiers are: 1) Glass Greenhouse Franchise, 2) Glass Greenhouse Franchise / Cannabis Sector, and 3) Vertical Hydrogarden Stores.

Abeona Therapeutics to Present at Ladenburg Thalmann 2016 Healthcare Conference

Fri, 23 Sep 2016 07:03:00 EDT

Company COO to Present on September 27th at 9:30 am ET

CloudMedx Inc. and Sutter Physician Services Create Clinical Collaboration

Thu, 22 Sep 2016 16:48:47 EDT

Data Sharing, Analysis, and Outreach to Support Patient Health Outcomes

Fogarty Institute Accepting Applications for Medical Technology Startups

Thu, 22 Sep 2016 15:24:07 EDT

Institute Aims to Identify Emerging Medtech Companies With High Potential to Benefit Patients

KG Health Partners, Inc. Acquires Access Foot Care, Inc.

Thu, 22 Sep 2016 12:08:31 EDT

CLEARWATER, FL--(Marketwired - Sep 22, 2016) - KG Health Partners, Inc. (KGHP), a leading mobile podiatric care provider serving Florida's long-term care (LTC) facilities as a partner in the care continuum, announced today that it has acquired Access Foot Care, Inc., a group podiatry practice based in Tarpon Springs, Fla. With this acquisition, KGHP doubles the size of its physician and clinical support staff, allowing the company to better support its partner organizations across the state.

ProCare Pain Solutions' Dr. Fred Davis Promoted to Clinical Associate Professor in the College of Human Medicine at Michigan State University

Thu, 22 Sep 2016 11:00:00 EDT

GRAND RAPIDS, MI--(Marketwired - September 22, 2016) - ProCare Pain Solutions, a NAPA company, is proud to announce its President and Cofounder, Fred Davis, MD was recently promoted to the rank of Clinical Associate Professor in the College of Human Medicine at Michigan State University. His new appointment is an acknowledgement of his outstanding academic efforts, his accomplishments as a researcher and reputation as a mentor. Previously, Dr. Davis served as the Clinical Assistant Professor at the college.

Olive Fertility Centre Voted Best Fertility Clinic in Vancouver for the Second Year

Thu, 22 Sep 2016 10:00:00 EDT

VANCOUVER, BC--(Marketwired - September 22, 2016) - Olive Fertility Centre is proud to announce that they have been voted Best Fertility Clinic in Vancouver in the Georgia Straight Best of Vancouver Awards 2016.

Total Market Access Budgets are Increasing for Most Drug Companies

Thu, 22 Sep 2016 08:54:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - September 22, 2016) - A new study published by Cutting Edge Information found an average $2 million increase in total market access spending by Top 10 pharmaceutical companies over a two-year period.

Dr. Edward Messing, Chief of Urology, U Rochester Medical Center Joins Imagin Medical's Scientific Board of Advisors

Thu, 22 Sep 2016 08:30:00 EDT

Imagin Medical Is the Developer of the Ultrasensitive i/Blue Imaging System That Will Establish a New Standard of Care for Urologists in Detecting Bladder Cancer Through Endoscopes

Massage Addict and The Arthritis Society Introduce "Hands On for Arthritis"

Thu, 22 Sep 2016 08:00:00 EDT

Therapeutic Massage Clinics Will Donate $5 for Every Massage Given on September 24-25

Mentor Capital, a Leading Cannabis Industry Financier, Signs With GreenVision Systems, an Emerging Puerto Rico Medical Cannabis & Hemp Farming Company

Thu, 22 Sep 2016 07:00:00 EDT

LAS VEGAS, NV--(Marketwired - Sep 22, 2016) - StereoVision Entertainment Inc., a publicly traded Nevada corporation (OTC PINK: SVSN), announced today that their jointly owned subsidiary GreenVision Systems, a Puerto Rico medical cannabis company, has signed Mentor Capital, Inc. (OTCQB: MNTR) to advise on financing and optimizing GreenVision's rapid growth in Puerto Rico's emerging medical cannabis market. GreenVision is financing its start-up with a convertible debenture for StereoVision's publicly traded stock. This first round will be directed to licensing costs for cannabis cultivation, manufacturing, and transportation in Puerto Rico, and GreenVision's filing an S-1 registration statement with the SEC. For details, accredited investors can contact

Panther Biotechnology Announces Entry Into Letter of Intent to Acquire Brown Technical Media Corp.

Thu, 22 Sep 2016 07:00:00 EDT

LA JOLLA, CA--(Marketwired - Sep 22, 2016) - Panther Biotechnology, Inc. (OTC PINK: PBYA), or Panther, a company which has historically been specializing in the development of enhanced therapeutics for the treatment of neoplastic and autoimmune disorders and had previously been operating in the EDGAR filings industry, is pleased to announce today that it has signed a letter of intent relating to a proposed share exchange transaction with Brown Technical Media Corp., or Brown, a privately held corporation in Houston, Texas. The letter of intent contemplates Brown entering into a share exchange agreement with Panther whereby all of the outstanding capital stock of Brown will be exchanged for shares of Panther common stock. In addition, an earn-out provision is contemplated whereby in the event certain defined revenue targets are met, additional shares of Panther will be issued to certain of Brown's shareholders. This transaction is strategically designed to diversify Panther's product opportunities and offer a more favorable risk reward profile for its shareholders. Assuming the completion of the transaction, Panther's shareholders will have exposure to not only the clinical development of Transferrin Doxorubicin, but also a revenue generating business that has been experiencing significant growth over the last two years.

Game Ready(R) Publishes Guides to Faster Ankle Injury Healing & Rehab Cold and Compression Systems

Thu, 22 Sep 2016 03:00:00 EDT

Cold and Compression Therapy Leader Offers E-Book on Ankle Injury Recovery, Comparison Chart

Kleo Pharmaceuticals Inc. Appoints Roy Prieb as Chief Operating Officer and Chief Financial Officer

Thu, 22 Sep 2016 03:00:00 EDT

NEW HAVEN, CT--(Marketwired - September 22, 2016) - Kleo Pharmaceuticals Inc., a biotechnology company pioneering a new class of immunotherapies utilizing small molecules to activate an individual's own immune system to fight against cancers and infectious diseases, announced today the appointment of Roy Prieb as Chief Operating Officer and Chief Financial Officer effective immediately. Mr. Prieb will also serve on the company's Board of Directors. He is a co-founder of Kleo Pharmaceuticals and the entrepreneur who secured its technology license from Yale University and organized the company's series A financing, which was led by Biohaven Pharmaceuticals.